Search results
Sen. Hassan slams GlaxoSmithKline over cost of asthma inhalers
New Hampshire Union Leader· 10 hours agoPharmaceutical giant GlaxoSmithKline is sidestepping its pledge to lower asthma inhaler prices, a...
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Reuters· 7 days agoGlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of...
GSK profit drops in first quarter on higher costs
Digital Journal· 22 hours agoBritish drugmaker GlaxoSmithKline on Wednesday said its net profit fell 23 percent in the first quarter as the company faced higher exceptional costs...
Two possible bird flu vaccines could be available within weeks, if needed
NBC News via Yahoo News· 13 hours agoThe U.S. has two vaccines ready that could begin shipping widely within a few weeks if the H5N1 bird...
Wall Street stocks end mostly down while dollar slides after Fed decision
AFP via Yahoo Finance· 12 hours agoWall Street stocks finished a choppy session mostly lower while the dollar retreated Wednesday after...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
NBC Washington· 2 days agoThe Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with...
Janssen adopts J&J name as part of global rebranding effort
Pharmaceutical Technology via Yahoo Finance· 19 hours agoAs part of the changes, the company also unveiled a new logo. Last year, GSK rebranded as it...
Amazon, AMD, and Super Micro Sing the Same Sad Song, and 5 Other Things to Know Before Markets Open.
Barrons.com· 20 hours agoTesla takes action amid slowing growth at fast-charging stations, Walmart unveils premium...
Women need not fear menopause hormone drugs, major health study finds
Anchorage Daily News· 19 hours agoMore than two decades ago, the shocking results of a major women’s health study challenged the...
These Are the Drugs America Is Running Short On
247wallst.com· 3 days agoDrug shortages in America are the result of supply line challenges, profit-based operations, and company closures.